Earlier this year, Mead Johnson was hit with a $60 million verdict and Abbott Laboratories with an even larger $495 million verdict in trials linking the milk-based infant formula the companies make with necrotizing enterocolitis, or NEC—a life-threatening intestinal disease that affects premature infants.